Finland to prioritise FP7 agreement and boosting innovation during Presidency

EU PresidencyFinland has announced its priorities for research and innovation during its Presidency of the EU, started on 1 July: concluding negotiations on the Seventh Framework Programme (FP7); and developing a broad-based innovation policy.

The Presidency will kick-off its six months at the helm of the EU with an informal Competitiveness Council on 10 and 11 July in Jyväskylä, where it will present a background paper on innovation.

"I believe that innovation policy is very much the joint responsibility of all ministers responsible for the various strands of the Competitiveness Council and, during the meeting, would like to hear your views on the topic. It is my intention to take this theme forward together with the Commission during the autumn," writes Mauri Pekkarinen, Finland's Minister for Trade and Industry, in his letter of invitation.

The innovation policy that Finland wishes to promote will be based largely on the recommendations outlined in the expert group report, chaired by former Finnish Prime Minister Esko Aho, and prepared on behalf of the European Commission. "The basic point of departure is a broadening of perspectives to include the demand for innovation," states the Finnish government.

The way to improve the EU's innovation policy is to develop markets that encourage innovation and create new demand, states the Finnish priorities paper. Important factors listed include standards, public procurements, enhancing the efficient operation of the market, mobility of research resources, and closer cooperation between universities and businesses.

On research, Finland aims to conclude negotiations on FP7 so that the programme can be launched at the start of 2007. A formal Competitiveness Council will take place on 25 September.

Further information on the research and innovation activities of the Finnish Presidency will be available from 3 July at:
http://cordis.europa.eu/finland

For other information on the Finnish Presidency, please see:
http://www.eu2006.fi

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...